Literature DB >> 15271787

Angiotensin II-induced insulin resistance and protein tyrosine phosphatases.

Mario B Marrero1, David Fulton, David Stepp, David M Stern.   

Abstract

Although the importance of protein tyrosine phosphorylation by tyrosine kinases in mitogenic signaling is well-accepted, recent studies also suggest that tyrosine dephosphorylation by protein tyrosine phosphatases (PTPases) play an equally important role. For example, both angiotensin II (Ang II) and insulin are known to mediate protein tyrosine phosphorylation and dephosphorylation events. These apparently paradoxical effects of Ang II and insulin suggest that both convergent and divergent intracellular signaling cascades are stimulated downstream of their respective receptors, producing diverse cellular responses. In this review, we discuss the hypothesis that the protein tyrosine phosphatase (PTPase), PTP-1B, plays a central role in Ang II-induced insulin resistance by inhibiting activation of the insulin receptor. We hypothesize that Ang II-induced PTP-1B activation leads to dephosphorylation of the insulin receptor and that this signaling pathway underlies the maladaptive responses observed in diabetic vascular and renal tissue during type II diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271787     DOI: 10.1161/01.ATV.0000140059.04717.f3

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

Review 1.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

2.  Association of polymorphisms of angiotensin I converting enzyme 2 with retinopathy in type 2 diabetes mellitus among Chinese individuals.

Authors:  N Meng; Y Zhang; J Ma; H Li; F Zhou; Y Qu
Journal:  Eye (Lond)       Date:  2014-10-31       Impact factor: 3.775

3.  Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: roles of Protein Tyrosine Phosphatase-1B.

Authors:  Pimonrat Ketsawatsomkron; David W Stepp; David J Fulton; Mario B Marrero
Journal:  Vascul Pharmacol       Date:  2010-06-25       Impact factor: 5.773

4.  Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.

Authors:  Imene Tabbi-Anneni; Jonathan Buchanan; Robert C Cooksey; E Dale Abel
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

5.  Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.

Authors:  Araceli Arellano-Plancarte; Judith Hernandez-Aranda; Kevin J Catt; J Alberto Olivares-Reyes
Journal:  Biochem Pharmacol       Date:  2009-10-29       Impact factor: 5.858

6.  Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression.

Authors:  J-C Zhong; X-Y Yu; Q-X Lin; X-H Li; X-Z Huang; D-Z Xiao; S-G Lin
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

7.  Exploring metabolic dysfunction in chronic kidney disease.

Authors:  Adrian D Slee
Journal:  Nutr Metab (Lond)       Date:  2012-04-26       Impact factor: 4.169

8.  Activation of the STAT3/microRNA-21 pathway participates in angiotensin II-induced angiogenesis.

Authors:  Li-Yuan Chen; Xue Wang; Xiao-Long Qu; Li-Na Pan; Ze-Yang Wang; Yong-Hui Lu; Hou-Yuan Hu
Journal:  J Cell Physiol       Date:  2019-04-04       Impact factor: 6.384

9.  Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartan.

Authors:  Basma Ismail; Robert A deKemp; Tayebeh Hadizad; Kumiko Mackasey; Rob S Beanlands; Jean N DaSilva
Journal:  EJNMMI Res       Date:  2016-06-23       Impact factor: 3.138

Review 10.  The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review.

Authors:  Luciana M A Borém; João F R Neto; Igor V Brandi; Deborah F Lelis; Sergio H S Santos
Journal:  Hypertens Res       Date:  2018-04-10       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.